Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.16B |
| 2 |
Bank of America
BAC
|
+$855M |
| 3 |
Comcast
CMCSA
|
+$620M |
| 4 |
Amazon
AMZN
|
+$505M |
| 5 |
Micron Technology
MU
|
+$486M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Goldman Sachs
GS
|
+$441M |
| 2 |
Palo Alto Networks
PANW
|
+$300M |
| 3 |
Verizon
VZ
|
+$286M |
| 4 |
Fidelity National Information Services
FIS
|
+$285M |
| 5 |
Stanley Black & Decker
SWK
|
+$244M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.22% |
| 2 | Financials | 6.16% |
| 3 | Industrials | 5.09% |
| 4 | Consumer Discretionary | 4.89% |
| 5 | Healthcare | 4.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
6101
CALL
Genesis Energy
GEL
$1.93B
| $337K | ﹤0.01% |
15,100
-1,000
| -6% | -$23.1K |
|
6102
CALL
Pediatrix Medical
MD
$2.16B
| $337K | ﹤0.01% |
6,300
-6,900
| -52% | -$326K |
|
|
MTL
6103
DELISTED
Mechel PAO American Depository Shares, each representing two ordinary shares (ADSs)
MTL
| $337K | ﹤0.01% |
64,071
+25,163
| +65% | +$121K |
|
|
WLH
6104
PUT
DELISTED
WILLIAM LYON HOMES
WLH
| $337K | ﹤0.01% |
+11,600
| New | +$314K |
|
6105
CALL
Commault Systems
CVLT
$6.1B
| $336K | ﹤0.01% |
6,400
+1,000
| +19% | +$55.3K |
|
6106
CALL
Maximus
MMS
$2.89B
| $336K | ﹤0.01% |
4,700
+1,300
| +38% | +$87.5K |
|
6107
CALL
Rockwell Medical
RMTI
$29.2M
| $336K | ﹤0.01% |
525
+128
| +32% | +$90.2K |
|
|
GNMK
6108
DELISTED
GenMark Diagnostics, Inc
GNMK
| $336K | ﹤0.01% |
80,609
-7,534
| -9% | -$45.3K |
|
|
ESL
6109
PUT
DELISTED
Esterline Technologies
ESL
| $336K | ﹤0.01% |
4,500
-400
| -8% | -$32.9K |
|
6110
Braskem
BAK
$777M
| $335K | ﹤0.01% |
+12,752
| New | +$364K |
|
6111
Clearway Energy Class C
CWEN
$7.01B
| $335K | ﹤0.01% |
+17,739
| New | +$337K |
|
6112
PUT
Dolby
DLB
$5.84B
| $335K | ﹤0.01% |
5,400
+1,900
| +54% | +$115K |
|
6113
PUT
DHT Holdings
DHT
$3.15B
| $334K | ﹤0.01% |
92,900
+42,700
| +85% | +$165K |
|
6114
CALL
Ecopetrol
EC
$35.3B
| $334K | ﹤0.01% |
22,800
-5,100
| -18% | -$58.5K |
|
6115
PUT
Energy Recovery
ERII
$426M
| $334K | ﹤0.01% |
38,200
+6,300
| +20% | +$57.4K |
|
6116
PUT
Installed Building Products
IBP
$6.39B
| $334K | ﹤0.01% |
+4,400
| New | +$305K |
|
6117
Laureate Education
LAUR
$5.18B
| $334K | ﹤0.01% |
24,644
-48,018
| -66% | -$629K |
|
6118
Ligand Pharmaceuticals
LGND
$5.87B
| $334K | ﹤0.01% |
3,915
-2,148
| -35% | -$186K |
|
6119
Shenandoah Telecom
SHEN
$735M
| $334K | ﹤0.01% |
9,871
+1,380
| +16% | +$50.8K |
|
6120
PUT
Sunstone Hotel Investors
SHO
$2.03B
| $334K | ﹤0.01% |
+20,200
| New | +$334K |
|
6121
Tilly's
TLYS
$122M
| $334K | ﹤0.01% |
22,617
+6,460
| +40% | +$86.6K |
|
|
LXFT
6122
PUT
DELISTED
Luxoft Holding, Inc.
LXFT
| $334K | ﹤0.01% |
+6,000
| New | +$300K |
|
|
FM
6123
DELISTED
iShares Frontier and Select EM ETF
FM
| $334K | ﹤0.01% |
10,073
+2,395
| +31% | +$77.3K |
|
6124
PUT
Alamos Gold
AGI
$14B
| $333K | ﹤0.01% |
51,200
+14,400
| +39% | +$94K |
|
|
IBKC
6125
CALL
DELISTED
IBERIABANK Corp
IBKC
| $333K | ﹤0.01% |
+4,300
| New | +$331K |
|
Similar funds
Ken Griffin's Q4 2017 Portfolio in Review
As of Q4 2017, Ken Griffin held 8,908 positions worth $164B, up 26% from $130B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Ken Griffin deployed $21.1B of net new capital in Q4 2017, opening 1,440 new positions and adding to 3,569 existing holdings. Its largest new stake was Celgene Corp: 3,708,916 shares worth $387M.
By sector, the portfolio is most concentrated in Technology at 6.2% of assets, down from 7.2% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Goldman Sachs, an estimated $441M trimmed.
- Ken Griffin's largest Q4 2017 buy was Celgene Corp: 3,708,916 shares worth $387M.
- Ken Griffin added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $1.16B increase.
- Ken Griffin's biggest Q4 2017 reduction was Goldman Sachs, cutting an estimated $441M.
- Ken Griffin fully exited CR Bard Inc. in Q4 2017, selling an estimated $209M.
- Ken Griffin's ten largest holdings make up 19% of its $164B portfolio in Q4 2017.
- Ken Griffin opened 1,440 new positions and closed 988 in Q4 2017.
- Ken Griffin's portfolio value rose 26% quarter-over-quarter to $164B.
Based on Citadel Advisors's 13F filing for Q4 2017, filed 9 Feb 2018.